Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Harmony Biosciences Holdings, Inc. (HRMY)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 63,680,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Harmony Biosciences is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological disorders. Co.'s product, WAKIX (pitolisant), is a first-in-class molecule with a novel mechanism of action, specifically designed to increase histamine signaling in the brain by binding to H3 receptors. WAKIX is used for the treatment of excessive daytime sleepiness (EDS), in adult patients with narcolepsy, focusing on the treatment of EDS associated with Prader-Willi Syndrome and myotonic dystrophy. Co. is also exploring pitolisant for treatments in other rare neurological disorders affected by fatigue and cognitive impairments.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 6,987 120,963 9,415,262 9,427,435
Total Sell Value $227,386 $4,586,943 $286,973,545 $287,363,081
Total People Sold 1 3 5 5
Total Sell Transactions 1 11 20 22
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 218
  Page 1 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Budur Kumar CHIEF MEDICAL OFFICER   •       –      –    2025-05-01 4 D $29.86 $264,828 D/D (8,869) 9,881     -
   Budur Kumar CHIEF MEDICAL OFFICER   •       –      –    2025-05-01 4 OE $0.00 $0 D/D 18,750 18,750     -
   Kapadia Sandip CHIEF FINANCIAL OFFICER   •       –      –    2025-04-01 4 AS $32.48 $227,386 D/D (6,987) 0     -
   Kapadia Sandip CHIEF FINANCIAL OFFICER   •       –      –    2025-03-29 4 D $33.19 $265,985 D/D (8,014) 6,986     -
   Kapadia Sandip CHIEF FINANCIAL OFFICER   •       –      –    2025-03-29 4 OE $0.00 $0 D/D 15,000 15,000     -
   Dierks Jeffrey CHIEF COMMERCIAL OFFICER   •       –      –    2025-03-03 4 AS $32.61 $159,090 D/D (4,869) 0     -
   Dierks Jeffrey CHIEF COMMERCIAL OFFICER   •       –      –    2025-03-03 4 OE $8.22 $40,023 D/D 4,869 4,869     -
   Dierks Jeffrey CHIEF COMMERCIAL OFFICER   •       –      –    2025-01-27 4 AS $38.02 $61,941 D/D (1,629) 0     -
   Kapadia Sandip CHIEF FINANCIAL OFFICER   •       –      –    2025-01-27 4 AS $38.05 $67,547 D/D (1,775) 0     -
   Dierks Jeffrey CHIEF COMMERCIAL OFFICER   •       –      –    2025-01-24 4 D $38.01 $40,215 D/D (1,058) 1,629     -
   Dierks Jeffrey CHIEF COMMERCIAL OFFICER   •       –      –    2025-01-24 4 OE $0.00 $402,806 D/D 15,812 2,687     -
   Dierks Jeffrey CHIEF COMMERCIAL OFFICER   •       –      –    2025-01-24 4 AS $36.94 $489,634 D/D (13,125) 0     -
   Serafin Andrew CHIEF STRATEGY OFFICER   •       –      –    2025-01-24 4 D $38.01 $32,879 D/D (865) 1,635     -
   Serafin Andrew CHIEF STRATEGY OFFICER   •       –      –    2025-01-24 4 OE $0.00 $0 D/D 2,500 2,500     -
   Dayno Jeffrey M. PRESIDENT, CEO   •       •      –    2025-01-24 4 D $38.01 $173,592 D/D (4,567) 5,933     -
   Dayno Jeffrey M. PRESIDENT, CEO   •       •      –    2025-01-24 4 OE $0.00 $0 D/D 10,500 10,500     -
   Budur Kumar CHIEF MEDICAL OFFICER   •       –      –    2025-01-24 4 D $38.01 $43,750 D/D (1,151) 1,036     -
   Budur Kumar CHIEF MEDICAL OFFICER   •       –      –    2025-01-24 4 OE $0.00 $0 D/D 2,187 2,187     -
   Kapadia Sandip CHIEF FINANCIAL OFFICER   •       –      –    2025-01-24 4 D $38.01 $77,426 D/D (2,037) 1,775     -
   Kapadia Sandip CHIEF FINANCIAL OFFICER   •       –      –    2025-01-24 4 OE $0.00 $0 D/D 3,812 3,812     -
   Kapadia Sandip CHIEF FINANCIAL OFFICER   •       –      –    2025-01-21 4 AS $40.18 $1,004,598 D/D (25,000) 0     -
   Kapadia Sandip CHIEF FINANCIAL OFFICER   •       –      –    2025-01-21 4 OE $29.03 $725,750 D/D 25,000 25,000     -
   Dayno Jeffrey M. PRESIDENT, CEO   •       •      –    2025-01-21 4 AS $40.13 $774,245 D/D (19,293) 0     -
   Dayno Jeffrey M. PRESIDENT, CEO   •       •      –    2025-01-21 4 OE $8.22 $158,588 D/D 19,293 19,293     -
   Dierks Jeffrey CHIEF COMMERCIAL OFFICER   •       –      –    2025-01-21 4 AS $40.00 $44,920 D/D (1,123) 0     -
  218 Records found
  1  2  3  4  5  6  7  8  9   
  Page 1 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us